Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
1.030
-0.030 (-2.83%)
At close: Aug 1, 2025, 4:00 PM
1.050
+0.020 (1.94%)
After-hours: Aug 1, 2025, 6:10 PM EDT
Hyperfine Market Cap
Hyperfine has a market cap or net worth of $80.18 million as of August 1, 2025. Its market cap has decreased by -7.22% in one year.
Market Cap
80.18M
Enterprise Value
47.36M
1-Year Change
-7.22%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since January 27, 2021, Hyperfine's market cap has increased from $45.05M to $80.18M, an increase of 77.99%. That is a compound annual growth rate of 13.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 80.18M | 24.89% |
| Dec 31, 2024 | 64.19M | -19.95% |
| Dec 29, 2023 | 80.19M | 35.27% |
| Dec 30, 2022 | 59.28M | -88.32% |
| Dec 31, 2021 | 507.73M | 1,027.17% |
| Jan 27, 2021 | 45.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |